Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 518 participants.
Also called NCT05307237
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 518 participants
- Sponsor
- Registry
-
NCT05307237
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05307237. Randomized; single masking; primary purpose treatment. Start 2022-04-19 (actual); primary completion 2025-12-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)
- Acronym
- Cyber GEMS
- Condition
- Type 2 Diabetes
- Intervention (Device)
- Dexcom G6 Continous Glucose Monitoring Management
- Intervention (Device)
- Usual Care - Blinded Continuous Glucose Monitoring Management
- Lead sponsor
- Scripps Whittier Diabetes Institute
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct05307237- Content hash
06b265e444d1c47f4a5263deeecc31140ae8c69d2fbac1912b3a1593fe7b62b5